Cargando…
Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
Tablets containing metoprolol succinate and Compritol(®) 888ATO in the ratio of 1:2 yielded the desired sustained release profile in phosphate buffer pH 6.8 when evaluated using USP type II paddle apparatus and was selected as the optimized formulation. Robustness of optimized formulation was assess...
Autores principales: | Patere, Shilpa N., Kapadia, Chhanda J., Nagarsenker, Mangal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700717/ https://www.ncbi.nlm.nih.gov/pubmed/26798179 |
Ejemplares similares
-
In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design
por: Patel, J.K., et al.
Publicado: (2009) -
Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
por: Jagdale, SC, et al.
Publicado: (2011) -
Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012) -
The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets
por: Amador Ríos, Zoriely, et al.
Publicado: (2015) -
Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets
por: Alkrad, Jamal Alyoussef, et al.
Publicado: (2017)